U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900296) titled 'ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)' on March 21.
Brief Summary: This is a prospective observational study that will collect blood samples at 1-10 timepoints related to initiation of immunotherapy. The study may collect samples before the start of immunotherapy and/or at clinically significant timepoints during immunotherapy treatment.
Study Start Date: April, 2025
Study Type: OBSERVATIONAL
Condition:
Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Indiana University
Information provided by (Responsible Party): Tyler Andrew Shugg, Indiana University
Published by HT Digital Con...